Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Macular Degeneration | 15 | 2023 | 980 | 3.860 |
Why?
|
Dark Adaptation | 6 | 2023 | 219 | 2.890 |
Why?
|
Retinal Diseases | 8 | 2022 | 683 | 2.110 |
Why?
|
Wet Macular Degeneration | 5 | 2023 | 146 | 2.060 |
Why?
|
Vitreous Body | 6 | 2018 | 389 | 1.310 |
Why?
|
Tomography, Optical Coherence | 23 | 2023 | 2637 | 1.300 |
Why?
|
Metabolomics | 7 | 2023 | 1467 | 1.280 |
Why?
|
Fluorescein Angiography | 22 | 2023 | 936 | 1.070 |
Why?
|
Fibrinolysin | 2 | 2016 | 131 | 1.050 |
Why?
|
Ophthalmology | 2 | 2021 | 506 | 0.970 |
Why?
|
Visual Acuity | 16 | 2023 | 2520 | 0.920 |
Why?
|
Diabetic Retinopathy | 11 | 2023 | 1205 | 0.910 |
Why?
|
Choroidal Neovascularization | 6 | 2017 | 343 | 0.900 |
Why?
|
Choroid | 9 | 2018 | 317 | 0.880 |
Why?
|
Retina | 16 | 2022 | 2611 | 0.860 |
Why?
|
Geographic Atrophy | 2 | 2019 | 66 | 0.730 |
Why?
|
Porphyrins | 7 | 2006 | 348 | 0.730 |
Why?
|
Retinal Necrosis Syndrome, Acute | 1 | 2020 | 21 | 0.730 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2021 | 195 | 0.720 |
Why?
|
Ophthalmologic Surgical Procedures | 2 | 2017 | 349 | 0.670 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2020 | 194 | 0.660 |
Why?
|
Light Coagulation | 1 | 2017 | 72 | 0.630 |
Why?
|
Photosensitizing Agents | 7 | 2006 | 602 | 0.630 |
Why?
|
Fatty Acids, Unsaturated | 2 | 2020 | 546 | 0.600 |
Why?
|
Photochemotherapy | 7 | 2006 | 804 | 0.580 |
Why?
|
Vitreous Detachment | 1 | 2016 | 22 | 0.570 |
Why?
|
Eye Diseases | 2 | 2020 | 670 | 0.570 |
Why?
|
Fibrinolytic Agents | 2 | 2016 | 2156 | 0.530 |
Why?
|
Eye Infections, Fungal | 1 | 2016 | 110 | 0.510 |
Why?
|
Retinal Vein Occlusion | 3 | 2023 | 137 | 0.510 |
Why?
|
Retinal Drusen | 3 | 2021 | 66 | 0.500 |
Why?
|
Vascular Endothelial Growth Factor A | 8 | 2023 | 3502 | 0.500 |
Why?
|
Retinal Vessels | 9 | 2023 | 769 | 0.500 |
Why?
|
Endophthalmitis | 2 | 2016 | 263 | 0.480 |
Why?
|
Fungi | 1 | 2016 | 327 | 0.460 |
Why?
|
Phospholipase C gamma | 2 | 2011 | 128 | 0.460 |
Why?
|
Eye Infections, Bacterial | 1 | 2016 | 235 | 0.450 |
Why?
|
Proto-Oncogene Proteins c-cbl | 2 | 2011 | 119 | 0.450 |
Why?
|
Telemedicine | 2 | 2021 | 2853 | 0.450 |
Why?
|
Metabolome | 2 | 2023 | 881 | 0.450 |
Why?
|
Retinal Perforations | 2 | 2014 | 131 | 0.450 |
Why?
|
Peptide Fragments | 2 | 2016 | 5095 | 0.440 |
Why?
|
Lipids | 4 | 2022 | 3302 | 0.440 |
Why?
|
Macula Lutea | 3 | 2023 | 151 | 0.420 |
Why?
|
Ophthalmoscopes | 1 | 2012 | 23 | 0.420 |
Why?
|
Cross-Sectional Studies | 18 | 2023 | 24913 | 0.400 |
Why?
|
Retinal Artery | 1 | 2012 | 111 | 0.390 |
Why?
|
Fundus Oculi | 8 | 2022 | 472 | 0.380 |
Why?
|
Nematode Infections | 1 | 2009 | 22 | 0.350 |
Why?
|
Retinitis | 1 | 2009 | 35 | 0.350 |
Why?
|
Eye Infections, Parasitic | 1 | 2009 | 24 | 0.340 |
Why?
|
Vitrectomy | 4 | 2016 | 365 | 0.330 |
Why?
|
Retinal Detachment | 4 | 2018 | 411 | 0.330 |
Why?
|
Angiography | 2 | 2023 | 1636 | 0.310 |
Why?
|
Macular Edema | 3 | 2016 | 359 | 0.310 |
Why?
|
Retinal Neovascularization | 3 | 2021 | 244 | 0.290 |
Why?
|
Artificial Intelligence | 1 | 2020 | 2187 | 0.290 |
Why?
|
Choroid Diseases | 3 | 2018 | 66 | 0.280 |
Why?
|
Intravitreal Injections | 3 | 2023 | 345 | 0.280 |
Why?
|
Microscopy, Confocal | 1 | 2012 | 1969 | 0.270 |
Why?
|
Bacteria | 1 | 2016 | 2102 | 0.260 |
Why?
|
Photoreceptor Cells, Vertebrate | 2 | 2018 | 204 | 0.260 |
Why?
|
Diagnostic Techniques, Ophthalmological | 2 | 2018 | 246 | 0.260 |
Why?
|
Aged | 28 | 2023 | 162944 | 0.250 |
Why?
|
Prospective Studies | 17 | 2021 | 53187 | 0.240 |
Why?
|
Humans | 58 | 2023 | 742088 | 0.220 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5304 | 0.220 |
Why?
|
Middle Aged | 27 | 2023 | 213127 | 0.210 |
Why?
|
Neovascularization, Pathologic | 4 | 2023 | 2633 | 0.210 |
Why?
|
Epiretinal Membrane | 1 | 2022 | 68 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.210 |
Why?
|
Blindness | 2 | 2023 | 615 | 0.200 |
Why?
|
Angiogenesis Inhibitors | 3 | 2023 | 2038 | 0.200 |
Why?
|
Macaca fascicularis | 8 | 2006 | 908 | 0.200 |
Why?
|
Disease Models, Animal | 10 | 2019 | 18006 | 0.200 |
Why?
|
Vitreous Hemorrhage | 1 | 2021 | 48 | 0.190 |
Why?
|
Portugal | 1 | 2020 | 87 | 0.180 |
Why?
|
Fovea Centralis | 1 | 2020 | 118 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8328 | 0.180 |
Why?
|
Electrodes, Implanted | 1 | 2004 | 824 | 0.170 |
Why?
|
Prosthesis Implantation | 1 | 2004 | 641 | 0.170 |
Why?
|
Myopia | 1 | 2021 | 254 | 0.160 |
Why?
|
Body Fluids | 2 | 2019 | 319 | 0.160 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2020 | 226 | 0.160 |
Why?
|
Retinitis Pigmentosa | 1 | 2022 | 386 | 0.160 |
Why?
|
Exudates and Transudates | 2 | 2016 | 171 | 0.150 |
Why?
|
Female | 31 | 2022 | 379592 | 0.150 |
Why?
|
Receptors, Purinergic P2Y12 | 1 | 2018 | 132 | 0.150 |
Why?
|
Ocular Hypertension | 1 | 2019 | 197 | 0.150 |
Why?
|
Retinal Ganglion Cells | 3 | 2019 | 771 | 0.150 |
Why?
|
Area Under Curve | 1 | 2021 | 1653 | 0.150 |
Why?
|
Photography | 3 | 2018 | 521 | 0.150 |
Why?
|
Male | 31 | 2021 | 349538 | 0.150 |
Why?
|
Optic Disk | 2 | 2020 | 401 | 0.150 |
Why?
|
Contrast Sensitivity | 3 | 2023 | 244 | 0.150 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2022 | 664 | 0.150 |
Why?
|
Second Messenger Systems | 1 | 2017 | 206 | 0.140 |
Why?
|
Visual Field Tests | 1 | 2019 | 383 | 0.140 |
Why?
|
Scleral Buckling | 2 | 2016 | 84 | 0.140 |
Why?
|
Iris | 1 | 1997 | 239 | 0.140 |
Why?
|
Prostheses and Implants | 1 | 2004 | 1385 | 0.140 |
Why?
|
Angiography, Digital Subtraction | 1 | 1997 | 341 | 0.140 |
Why?
|
Sensory Thresholds | 1 | 2017 | 394 | 0.130 |
Why?
|
Postoperative Complications | 2 | 2017 | 15244 | 0.130 |
Why?
|
Tissue Adhesions | 1 | 2016 | 235 | 0.130 |
Why?
|
Complement Pathway, Alternative | 1 | 2015 | 126 | 0.130 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2017 | 419 | 0.130 |
Why?
|
Retinal Pigment Epithelium | 1 | 2018 | 302 | 0.130 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 546 | 0.120 |
Why?
|
Republic of Korea | 1 | 2016 | 538 | 0.120 |
Why?
|
Dyslipidemias | 1 | 2022 | 848 | 0.120 |
Why?
|
Aged, 80 and over | 9 | 2019 | 57683 | 0.120 |
Why?
|
Capillary Permeability | 3 | 2005 | 798 | 0.120 |
Why?
|
Uveal Neoplasms | 1 | 2016 | 310 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5724 | 0.110 |
Why?
|
Follow-Up Studies | 6 | 2021 | 39004 | 0.110 |
Why?
|
Antibodies, Monoclonal | 3 | 2006 | 9274 | 0.110 |
Why?
|
Lipid Metabolism | 2 | 2022 | 1887 | 0.110 |
Why?
|
Eye Injuries, Penetrating | 1 | 2014 | 115 | 0.110 |
Why?
|
Visual Fields | 1 | 2019 | 1049 | 0.100 |
Why?
|
Energy Intake | 1 | 2020 | 2147 | 0.100 |
Why?
|
Treatment Outcome | 6 | 2023 | 62966 | 0.100 |
Why?
|
Dietary Fats | 1 | 2020 | 2017 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2020 | 11695 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 2 | 2022 | 3770 | 0.100 |
Why?
|
Vision Disorders | 1 | 2019 | 1057 | 0.100 |
Why?
|
Laser Coagulation | 2 | 2009 | 326 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2011 | 544 | 0.090 |
Why?
|
Chorioallantoic Membrane | 1 | 2010 | 47 | 0.090 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2203 | 0.090 |
Why?
|
Microglia | 1 | 2018 | 1261 | 0.090 |
Why?
|
Cholesterol, HDL | 1 | 2016 | 1813 | 0.090 |
Why?
|
Animals | 19 | 2019 | 168561 | 0.090 |
Why?
|
Equipment Failure Analysis | 1 | 2012 | 867 | 0.080 |
Why?
|
Retrospective Studies | 10 | 2023 | 77098 | 0.080 |
Why?
|
Chick Embryo | 1 | 2010 | 981 | 0.080 |
Why?
|
Neoplasms, Second Primary | 1 | 2016 | 1052 | 0.080 |
Why?
|
Case-Control Studies | 4 | 2018 | 21719 | 0.080 |
Why?
|
Enzyme Activation | 2 | 2011 | 3701 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2021 | 13921 | 0.070 |
Why?
|
Cholesterol, LDL | 1 | 2016 | 2354 | 0.070 |
Why?
|
Indocyanine Green | 2 | 1999 | 238 | 0.070 |
Why?
|
Life Style | 1 | 2018 | 3824 | 0.070 |
Why?
|
Liposomes | 3 | 1999 | 758 | 0.070 |
Why?
|
Intraocular Pressure | 3 | 2020 | 1274 | 0.070 |
Why?
|
Endothelial Growth Factors | 2 | 2000 | 694 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2023 | 12220 | 0.070 |
Why?
|
Risk Factors | 6 | 2018 | 72145 | 0.070 |
Why?
|
Lymphokines | 2 | 2000 | 949 | 0.070 |
Why?
|
Choroid Neoplasms | 1 | 2006 | 175 | 0.070 |
Why?
|
Ciliary Body | 1 | 2006 | 172 | 0.070 |
Why?
|
Mice, Inbred C57BL | 6 | 2019 | 21821 | 0.070 |
Why?
|
Injections | 2 | 2006 | 840 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2018 | 3957 | 0.060 |
Why?
|
Software | 1 | 2019 | 4434 | 0.060 |
Why?
|
Endothelium, Vascular | 3 | 2011 | 4455 | 0.060 |
Why?
|
Burkitt Lymphoma | 1 | 2006 | 328 | 0.060 |
Why?
|
Blood Vessels | 1 | 2010 | 1124 | 0.060 |
Why?
|
Mass Screening | 1 | 2020 | 5238 | 0.060 |
Why?
|
Adult | 11 | 2022 | 213712 | 0.060 |
Why?
|
Aorta, Thoracic | 1 | 2010 | 1080 | 0.060 |
Why?
|
Comorbidity | 1 | 2018 | 10372 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5133 | 0.060 |
Why?
|
Equipment Design | 1 | 2012 | 3582 | 0.060 |
Why?
|
Macrophages | 1 | 2018 | 5655 | 0.060 |
Why?
|
Glaucoma | 2 | 2019 | 1152 | 0.060 |
Why?
|
Cell Division | 1 | 2011 | 4564 | 0.060 |
Why?
|
Logistic Models | 1 | 2018 | 13403 | 0.060 |
Why?
|
United States | 4 | 2020 | 69693 | 0.060 |
Why?
|
Chronic Disease | 1 | 2018 | 9144 | 0.060 |
Why?
|
Retinal Degeneration | 2 | 2019 | 414 | 0.050 |
Why?
|
Blotting, Western | 1 | 2010 | 5180 | 0.050 |
Why?
|
Safety | 2 | 2005 | 1185 | 0.050 |
Why?
|
Diet | 1 | 2020 | 7923 | 0.050 |
Why?
|
Ischemia | 2 | 2023 | 1911 | 0.050 |
Why?
|
Time Factors | 3 | 2021 | 40054 | 0.050 |
Why?
|
Cell Death | 2 | 2018 | 1695 | 0.050 |
Why?
|
Phenotype | 1 | 2018 | 16331 | 0.050 |
Why?
|
Enzyme Inhibitors | 2 | 2010 | 3800 | 0.050 |
Why?
|
Body Mass Index | 1 | 2018 | 12695 | 0.050 |
Why?
|
Swine | 1 | 2010 | 5934 | 0.050 |
Why?
|
Mice | 8 | 2019 | 81045 | 0.040 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2000 | 225 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15530 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 13853 | 0.040 |
Why?
|
Carrier State | 1 | 2022 | 518 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2006 | 6483 | 0.040 |
Why?
|
Retinal Vein | 1 | 1997 | 47 | 0.040 |
Why?
|
Dextrans | 1 | 2000 | 592 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2019 | 3760 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2011 | 19223 | 0.040 |
Why?
|
Melanoma | 1 | 2016 | 5462 | 0.040 |
Why?
|
GTP-Binding Proteins | 1 | 2022 | 970 | 0.040 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 1997 | 147 | 0.040 |
Why?
|
Atrophy | 1 | 2022 | 1576 | 0.040 |
Why?
|
Microvessels | 1 | 2021 | 544 | 0.040 |
Why?
|
Prosthesis Design | 1 | 2004 | 2110 | 0.040 |
Why?
|
Epoxide Hydrolases | 1 | 2017 | 122 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14720 | 0.040 |
Why?
|
Mice, Knockout | 2 | 2010 | 14554 | 0.040 |
Why?
|
Young Adult | 3 | 2018 | 56350 | 0.030 |
Why?
|
Prognosis | 1 | 2016 | 29010 | 0.030 |
Why?
|
Hyperoxia | 1 | 1997 | 262 | 0.030 |
Why?
|
Body Weights and Measures | 1 | 2016 | 211 | 0.030 |
Why?
|
Infusions, Intravenous | 2 | 1999 | 2271 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2018 | 9735 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2004 | 1731 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2303 | 0.030 |
Why?
|
Visual Perception | 1 | 2004 | 1417 | 0.030 |
Why?
|
Coloring Agents | 1 | 1997 | 565 | 0.030 |
Why?
|
Nitric Oxide Synthase | 1 | 1997 | 916 | 0.030 |
Why?
|
Eye Infections | 1 | 2014 | 64 | 0.030 |
Why?
|
Pigment Epithelium of Eye | 1 | 2014 | 220 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2012 | 19862 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2019 | 11363 | 0.030 |
Why?
|
Lens Capsule, Crystalline | 1 | 1992 | 43 | 0.030 |
Why?
|
Drug Substitution | 1 | 2015 | 281 | 0.030 |
Why?
|
Laser Therapy | 1 | 1999 | 1071 | 0.030 |
Why?
|
Drug Carriers | 1 | 1996 | 692 | 0.030 |
Why?
|
Cell Survival | 2 | 2018 | 5872 | 0.020 |
Why?
|
Uveitis | 1 | 2014 | 375 | 0.020 |
Why?
|
SEER Program | 1 | 2016 | 1507 | 0.020 |
Why?
|
Observer Variation | 1 | 2016 | 2593 | 0.020 |
Why?
|
Light | 1 | 1996 | 1374 | 0.020 |
Why?
|
Blood Pressure | 2 | 2016 | 8541 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2615 | 0.020 |
Why?
|
Leukocytes | 1 | 2017 | 2039 | 0.020 |
Why?
|
Cell Count | 2 | 2006 | 1831 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 5171 | 0.020 |
Why?
|
Incidence | 2 | 2016 | 20928 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3862 | 0.020 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2000 | 772 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2015 | 4742 | 0.020 |
Why?
|
Tyrosine | 1 | 2011 | 1460 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15194 | 0.020 |
Why?
|
Tonometry, Ocular | 1 | 2006 | 237 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2006 | 8829 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2020 | 3336 | 0.020 |
Why?
|
Regression Analysis | 1 | 2015 | 6452 | 0.020 |
Why?
|
Mice, Inbred DBA | 1 | 2006 | 642 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2006 | 643 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6171 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2022 | 7873 | 0.020 |
Why?
|
Antigens, CD | 1 | 2015 | 4024 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2017 | 3455 | 0.020 |
Why?
|
Gene Expression | 1 | 1997 | 7790 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4029 | 0.010 |
Why?
|
Adolescent | 3 | 2016 | 85649 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9846 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1997 | 13029 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2006 | 13019 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2006 | 2645 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2006 | 1849 | 0.010 |
Why?
|
Neoplasms | 1 | 2011 | 21596 | 0.010 |
Why?
|
Blood Glucose | 1 | 2016 | 6249 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12344 | 0.010 |
Why?
|
Ultrasonography | 1 | 2014 | 5978 | 0.010 |
Why?
|
HIV Seropositivity | 1 | 2006 | 970 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7716 | 0.010 |
Why?
|
Genotype | 1 | 2015 | 12946 | 0.010 |
Why?
|
Cytokines | 1 | 2014 | 7317 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 8436 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12958 | 0.010 |
Why?
|
Retreatment | 1 | 1999 | 604 | 0.010 |
Why?
|
Molecular Weight | 1 | 2000 | 2255 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2000 | 1420 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 1997 | 255 | 0.010 |
Why?
|
Microspheres | 1 | 2000 | 777 | 0.010 |
Why?
|
Retinal Artery Occlusion | 1 | 1997 | 74 | 0.010 |
Why?
|
N-Methylaspartate | 1 | 1997 | 231 | 0.010 |
Why?
|
Optic Nerve | 1 | 1999 | 548 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1997 | 1581 | 0.010 |
Why?
|
Optic Nerve Diseases | 1 | 1999 | 327 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 40450 | 0.010 |
Why?
|
Infant | 1 | 2016 | 35070 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 10943 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17400 | 0.010 |
Why?
|
Child, Preschool | 1 | 2016 | 40955 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 35342 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20086 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1997 | 1869 | 0.010 |
Why?
|
Lenses, Intraocular | 1 | 1992 | 142 | 0.010 |
Why?
|
Cataract Extraction | 1 | 1992 | 482 | 0.000 |
Why?
|
Child | 1 | 2016 | 77478 | 0.000 |
Why?
|
Signal Transduction | 1 | 2011 | 23387 | 0.000 |
Why?
|
RNA | 1 | 1997 | 2747 | 0.000 |
Why?
|
Oxygen | 1 | 1997 | 4169 | 0.000 |
Why?
|